Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis

NCT04987307 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
221
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated due to meeting a prespecified futility rule and not related to any safety concerns.

Conditions

Interventions

Sponsor

Amgen